Tue, 25 Nov 2014 21:32:05 GMT ~ Alnylam to Webcast Presentations at Upcoming Investor Conferences
[at noodls] - 11.25.2014 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the ...
Tue, 25 Nov 2014 21:00:00 GMT ~ Alnylam to Webcast Presentations at Upcoming Investor Conferences
[Business Wire] - Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today announced that management will present a company overview at the 2014 Deutsche Bank BioFEST on Tuesday, December 2, 2014 at 2:15 p.m.
Mon, 17 Nov 2014 22:08:29 GMT ~ Alnylam Presents New Pre-Clinical Data on RNAi Therapeutic Programs for Cardio-Metabolic Diseases at American Heart Association Scientific Sessions 2014
[at noodls] - 11.17.2014 - New Non-Human Primate Data on ALN-PCSsc Show Clamped Knockdown of PCSK9 up to 92% and LDL-C Reductions of up to 77% with Monthly Subcutaneous Dosing Regimen; Phase 1 Study with ALN-PCSsc on ...
Mon, 17 Nov 2014 22:00:00 GMT ~ Alnylam Presents New Pre-Clinical Data on RNAi Therapeutic Programs for Cardio-Metabolic Diseases at American Heart Association Scientific Sessions 2014
[Business Wire] - Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data from its investigational RNAi therapeutic programs toward genetically validated targets in development for the treatment of cardiovascular metabolic diseases, including: ALN-PCSsc targeting PCSK9 for the treatment of hypercholesterolemia; ALN-AC3 targeting apolipoprotein ...
Link: http://www.otcmarkets.com/stock/ALNY/company-info Ticker: $ALNY OTC Market Place: Not Available CIK code: 0001178670 Company name: Alnylam Pharmaceuticals, Inc. Company website: http://www.alnylam.com Incorporated In: DE, USA
$ALNY share structure
## source: otcmarkets.com
Market Value: $7,735,421,100 a/o Nov 28, 2014 Shares Outstanding: 76,931,090 a/o Oct 31, 2014 Float: Not Available Authorized Shares: Not Available Par Value: 0.0001 $ALNY extra dd links
Company name: Alnylam Pharmaceuticals, Inc. Company website: http://www.alnylam.com